Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants

Nattokinase (NK), known as a potent fibrinolytic and antithrombotic agent, has been shown to have antiatherosclerotic and lipid-lowering effects. However, data on human clinical studies are limited. In this clinical study involving 1,062 participants, our objective was to examine the efficacy of NK...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongjie, Chen, Jiepeng, Zhang, Fuping, Li, Yuanhui, Wang, Ronghua, Zheng, Qiang, Zhang, Xu, Zeng, Jun, Xu, Feng, Lin, Yiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441630/
https://www.ncbi.nlm.nih.gov/pubmed/36072877
http://dx.doi.org/10.3389/fcvm.2022.964977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441630/
https://www.ncbi.nlm.nih.gov/pubmed/36072877
http://dx.doi.org/10.3389/fcvm.2022.964977

Ejemplares similares